{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:19:37Z","timestamp":1792718377980,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1053\/j.gastro.2009.06.061","type":"journal-article","created":{"date-parts":[[2009,7,12]],"date-time":"2009-07-12T04:30:26Z","timestamp":1247373026000},"page":"1250-1260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":381,"title":["Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab"],"prefix":"10.1053","volume":"137","author":[{"given":"William J.","family":"Sandborn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Rutgeerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G.","family":"Feagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Reinisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jewel","family":"Johanns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Horgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Rachmilewitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Hanauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary R.","family":"Lichtenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem J.S.","family":"de Villiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Present","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce E.","family":"Sands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Fr\u00e9d\u00e9ric","family":"Colombel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2009.06.061_bib1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1053\/j.gastro.2006.11.015","article-title":"Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years","volume":"132","author":"Hoie","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2009.06.061_bib2","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1053\/j.gastro.2005.12.037","article-title":"Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota (comment)","volume":"130","author":"Jess","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2009.06.061_bib3","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/S1542-3565(04)00543-9","article-title":"Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County","volume":"2","author":"Winther","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2009.06.061_bib4","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/gut.38.2.234","article-title":"Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis","volume":"38","author":"Penna","year":"1996","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2009.06.061_bib5","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1136\/gut.2005.090316","article-title":"Three-fold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis","volume":"55","author":"Waljee","year":"2006","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2009.06.061_bib6","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/01.sla.0000141157.32234.9d","article-title":"The effect of ageing on function and quality of life in ileal pouch patients: a single cohort experience of 409 patients with chronic ulcerative colitis","volume":"240","author":"Hahnloser","year":"2004","journal-title":"Ann Surg"},{"key":"10.1053\/j.gastro.2009.06.061_bib7","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1572-0241.2004.40036.x","article-title":"Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee","volume":"99","author":"Kornbluth","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 5","key":"10.1053\/j.gastro.2009.06.061_bib8","doi-asserted-by":"crossref","first-page":"V1","DOI":"10.1136\/gut.2004.043372","article-title":"Guidelines for the management of inflammatory bowel disease in adults (comment)","volume":"53","author":"Carter","year":"2004","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2009.06.061_bib9","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJM199406303302601","article-title":"Cyclosporine in severe ulcerative colitis refractory to steroid therapy","volume":"330","author":"Lichtiger","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2009.06.061_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00054725-200105000-00001","article-title":"Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study","volume":"7","author":"Sands","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2009.06.061_bib11","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1053\/j.gastro.2005.03.003","article-title":"Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study","volume":"128","author":"Jarnerot","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2009.06.061_bib12","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/0161-5890(93)90106-L","article-title":"Construction and initial characterization of a mouse-human chimeric anti-TNF antibody","volume":"30","author":"Knight","year":"1993","journal-title":"Mol Immunol"},{"key":"10.1053\/j.gastro.2009.06.061_bib13","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2009.06.061_bib14","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","article-title":"Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis","volume":"317","author":"Schroeder","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2009.06.061_bib15","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S1542-3565(04)00238-1","article-title":"Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease","volume":"2","author":"Hanauer","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2009.06.061_bib16","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.dld.2008.03.014","article-title":"Colectomy rate in acute severe ulcerative colitis in the infliximab era","volume":"40","author":"Aratari","year":"2008","journal-title":"Dig Liver Dis"},{"key":"10.1053\/j.gastro.2009.06.061_bib17","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.3748\/wjg.14.2544","article-title":"Use of infliximab in the prevention and delay of colectomy in severe steroid dependent and refractory ulcerative colitis","volume":"14","author":"Willert","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2009.06.061_bib18","series-title":"Infliximab treatment for ulcerative colitis: comparable clinical response, clinical remission, and mucosal healing in patients with disease duration <3 years vs \u22653 years","author":"Reinisch","year":"2008"},{"key":"10.1053\/j.gastro.2009.06.061_bib19","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00004836-199206000-00010","article-title":"Inflammatory bowel disease: medical cost algorithms","volume":"14","author":"Hay","year":"1992","journal-title":"J Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2009.06.061_bib20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00004836-199206000-00009","article-title":"Inflammatory bowel disease: costs-of-illness","volume":"14","author":"Hay","year":"1992","journal-title":"J Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2009.06.061_bib21","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3109\/00365529709002993","article-title":"Inflammatory bowel diseases: health care and costs in Sweden in 1994","volume":"32","author":"Blomqvist","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2009.06.061_bib22","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1053\/j.gastro.2006.05.052","article-title":"Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation","volume":"131","author":"Odes","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2009.06.061_bib23","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/ibd.20250","article-title":"Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004","volume":"13","author":"Nguyen","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2009.06.061_bib24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1572-0241.2006.00330.x","article-title":"Hospitalization, surgery, and readmission rates of IBD in Canada: a population-based study","volume":"101","author":"Bernstein","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2009.06.061_bib25","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cgh.2007.01.015","article-title":"Trends in hospitalization rates for inflammatory bowel disease in the United States","volume":"5","author":"Bewtra","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2009.06.061_bib26","unstructured":"Prescribing information for Remicade (infliximab) [package insert]. Malvern, PA: Centocor Ortho Biotech, Inc, 2008."},{"key":"10.1053\/j.gastro.2009.06.061_bib27","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/ncpgasthep0695","article-title":"Treatment with biologic therapies and the risk of cancer in patients with IBD","volume":"4","author":"Biancone","year":"2007","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2009.06.061_bib28","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/gut.2006.103564","article-title":"Risks and benefits of biologic therapy for inflammatory bowel diseases","volume":"56","author":"D'Haens","year":"2007","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2009.06.061_bib29","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(02)07882-0","article-title":"Sample size slippages in randomised trials: exclusions and the lost and wayward","volume":"359","author":"Schultz","year":"2002","journal-title":"Lancet"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508509011536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508509011536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:37:43Z","timestamp":1762162663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508509011536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0016508509011536"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2009.06.061","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2009.06.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2009.08.029","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2009.08.024","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 AGA Institute. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}